saplin

Compare funds

HDFC Mid Cap vs Kotak Mid Cap

Both are mid cap funds. Over the last 3 years HDFC Mid Cap returned 16.3% a year and Kotak Mid Cap 16.1%, against a category median of 16.4%. HDFC Mid Cap costs 0.73% a year and Kotak Mid Cap 0.54%. On the saplin Score HDFC Mid Cap rates 5.3 (Weak) and Kotak Mid Cap 6.3 (Neutral) within their category. 31.6% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

HDFC Mid CapKotak Mid CapCategory median
saplin Score (0–10)5.3 Weak6.3 Neutral—
1-year return3.1%3.0%4.9%
3-year return, a year16.3%16.1%16.4%
5-year return, a year17.7%15.1%14.3%
Volatility (standard deviation)16.1%18.6%18.3%
Sharpe ratio0.660.570.62
Beta0.840.950.95
Upside capture919898
Downside capture799290
Expense ratio (Direct)0.73%0.54%0.94%
Fund size₹1,05,346 cr₹69,655 cr₹7,096 cr
Number of holdings787474
Top 10 holdings, share of fund31.7%28.4%27.5%
Portfolio P/E28.127.634.1
Lead managerChirag Setalvad (19 yrs)Atul Bhole (3 yrs)—
Launched25 Jun 200730 Mar 2007—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

HDFC Mid Cap and Kotak Mid Cap have 31.6% of their portfolios in the same stocks (24 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsHDFC Mid CapKotak Mid Cap
IPCA Laboratories3.47%3.68%
The Federal Bank4.31%2.92%
Indian Bank3.17%2.48%
Fortis Healthcare2.42%3.62%
Mphasis2.06%3.10%
Vishal Mega Mart1.94%2.62%
Persistent Systems2.06%1.89%
Gland Pharma1.87%2.24%
Eternal1.47%1.64%
Coromandel International1.26%1.50%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.